Leucine Stabilizes Outer Mitochondrial Membrane Proteins by Inhibiting SEL1L-Mediated Degradation

The 2026 Nature Cell Biology study used targeted leucine depletion, SEL1L knockdown, and rescue experiments in human cell lines plus C. elegans mutants to demonstrate that leucine reduces SEL1L activity, preventing ubiquitin-mediated turnover of key outer-membrane transporters. This mechanism increased mitochondrial oxygen consumption rates under nutrient-replete conditions without altering inner-membrane complexes.

Beyond muscle protein synthesis, the finding links leucine to broader metabolic flexibility. The same pathway modulated fertility in worms with leucine catabolism defects and conferred survival advantages to lung cancer cells harboring leucine-metabolism mutations, suggesting tissue-specific trade-offs between energy output and proteostasis.

Prior work on mTORC1 and BCAA catabolism missed this SEL1L node because most assays examined steady-state protein levels rather than degradation kinetics under acute leucine pulses. The current data indicate leucine acts as a rapid rheostat rather than solely a chronic anabolic signal.

Future experiments must test whether chronic leucine elevation disrupts SEL1L’s quality-control function in post-mitotic tissues, a key gap before dietary modulation can be recommended.